Abstract
Immune regulation is an important mechanism in controlling the severity and duration of an immune response. Ongoing and destructive inflammation suggests a dysfunction in the immune regulation, while a spontaneous relapse or remission of disease suggests a successful immune-regulatory process. Understanding the regulatory mechanisms that control the balance between immunity and tolerance can provide potential new targets for therapeutic intervention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Woo P, Wedderburn LR (1998) Juvenile chronic arthritis. Lancet 351: 969–973
Wallace CA, Levinson JE (1991) Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin North Am 17: 891–905
Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM (1998) Revision of the proposed clas-sification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25: 1991–1994
Pugh MT, Southwood TR, Gaston JS (1993) The role of infection in juvenile chronic arthritis. Br J Rheumatol 32: 838–844
Benoist C, Mathis D (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2: 797–801
Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P (2000) Selective recruitment of polarized T cells expressing CCRS and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 43: 765–774
Grom AA, Hirsch R (2000) T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 12: 420–424
Glass DN, Giannini EH (1999) Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 42: 2261–2268
Thomson W, Barrett JH, Donn R, Pepper L, Kennedy LJ, Ollier WE, Silman AJ, Woo P, Southwood T (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) 41: 1183–1189
De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A (1992) Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol 10: 493–498
Lepore L, Pennesi M, Saletta S, Perticarari S, Presani G, Prodan M (1994) Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 12: 561–565
Thompson SD, Luyrink LK, Graham TB, Tsoras M, Ryan M, Passo MH, Glass DN (2001) Chemokine receptor CCR4 on CD4’ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4: IFN-gamma mRNA ratios. J Immunol 166: 6899–6906
Murray KJ, Grom AA, Thompson SD, Lieuwen D, Passo MH, Glass DN (1998) Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 25: 1388–1398
Crawley E, Kon S, Woo P (2001) Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 40: 574–578
Shevach EM (2000) Regulatory T cells in autoimmunity. Annu Rev Immunol 18: 423–449
Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN (2001) Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31: 1122–1131
Ang D, Liberek K, Skowyra D, Zylicz M, Georgopoulos C (1991) Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem 266: 24233–24236
Rees A, Scoging A, Mehlert A, Young DB, Ivanyi J (1988) Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur J Immunol 18: 1881–1887
Munk ME, Schoel B, Modrow S, Karr RW, Young RA, Kaufmann SH (1989) T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. J Immunol 143: 2844–2849
Holoshitz J, Matitiau A, Cohen IR (1984) Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73: 211–215
van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82: 5117–5120
van Eden W, van der ZR, Paul AG, Prakken BJ, Wendling U, Anderton SM, Wauben MH (1998) Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today 19: 303–307
van der ZR, Anderton SM, Prakken AB, Liesbeth Paul AG, van Eden W (1998) T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunity. Semin Immunol 10: 35–41
Boog CJ, Graeff-Meeder ER, Lucassen MA, van der ZR, Voorhorst-Ogink MM, van Kooten PJ, Geuze HJ, van Eden W (1992) Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med 175: 1805–1810
Graeff-Meeder ER, Rijkers GT, Voorhorst-Ogink MM, Kuis W, van der ZR, van Eden W, Zegers BJ (1993) Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res 34: 424–428
Graeff-Meeder ER, van Eden W, Rijkers GT, Prakken BJ, Kuis W, Voorhorst-Ogink MM, van der ZR, Schuurman HJ, Helders PJ, Zegers BJ (1995) Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 95: 934–940
Life P, Hassell A, Williams K, Young S, Bacon P, Southwood T, Gaston JS (1993) Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60. J Rheumatol 20: 1388–1396
Albani S, Ravelli A, Massa M, De Benedetti F, Andree G, Roudier J, Martini A, Carson DA (1994) Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. J Pediatr 124: 561–565
Graeff-Meeder ER, van der ZR, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JW, Zegers BJ, van Eden W (1991) Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 337: 1368–1372
Prakken AB, van Eden W, Rijkers GT, Kuis W, Toebes EA, Graeff-Meeder ER, van der ZR, Zegers BJ (1996) Autoreactivity to human heat-shock protein 60 predicts disease remission in oligorticular juvenile rheumatoid arthritis. Arthritis Rheum 39: 1826–1832
de Kleer IM, Kamphuis S, Rijkers GT, Scholtens L, Gordon G, de Jager W, Hafner R, van de Zee R, van Eden W, Kuis W et al (2003) The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30’ T cells capable of producing the regulatory cytokine IL-10. Arthritis Rheum 48: 2001–2010
Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M, Pizzolo G (1996) CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn’s syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol 26: 329–334
Manetti R, Annunziato F, Biagiotti R, Giudizi MG, Piccinni MP, Giannarini L, Sampognaro S, Parronchi P, Vinante F, Pizzolo G (1994) CD30 expression by CD8’ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8’CD30’ T cell clones in human immunodeficiency virus infection. J Exp Med 180: 2407–2411
Metzler B, Wraith DC (1996) Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis. Ann NY Acad Sci 778: 228–242
Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ (1986) Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 83: 7443–7446
Aspord C, Thivolet C (2002) Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 130: 204–211
Prakken BJ, van der ZR, Anderton SM, van Kooten PJ, Kuis W, van Eden W (1997) Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and non-microbially induced experimental arthritis. Proc Natl Acad Sci USA 94: 3284–3289
Prakken BJ, Roord S, van Kooten PJ, Wagenaar JP, van Eden W, Albani S, Wauben MH (2002) Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum 46: 1937–1946
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Basel AG
About this chapter
Cite this chapter
de Kleer, I.M., Prakken, B.P., Albani, S., Kuis, W. (2003). The development of immune therapy with HSP60 for juvenile idiopathic arthritis. In: van Eden, W. (eds) Heat Shock Proteins and Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8028-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8028-2_8
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9410-4
Online ISBN: 978-3-0348-8028-2
eBook Packages: Springer Book Archive